Anxio-depressive symptoms in Moroccan women with gynecological cancer: Relief factors.


Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
May 2021
Historique:
received: 29 09 2020
revised: 28 11 2020
accepted: 14 12 2020
pubmed: 24 3 2021
medline: 28 5 2021
entrez: 23 3 2021
Statut: ppublish

Résumé

Psychosocial determinants can affect the mental health of women who have been diagnosed with gynecological cancer. The aim of this study was to examine how social support and self-esteem are associated with anxiety and depression symptoms in women with gynecological cancer, and who are treated by radical surgery. A cross-sectional study was performed, within the oncology department of Ibn Rochd University Hospital, Casablanca, on 100 Moroccan women. They all had undergone radical surgery for gynecological cancer, hysterectomy and/or oophorectomy. Our results showed that patients with gynecological cancer treated by radical surgery exhibited high prevalence rates of anxiety (66%) and depression symptoms (59%). Associations showed that age, having children, medical coverage system, area of residence, working status and socioeconomic status were significantly related to the prevalence of anxiety and depression symptoms (P<0.05). The general social support, family support and significant other support besides high self-esteem reduce significantly the risk of getting anxiety and depression symptoms (P-values<0.05). Among patients with gynecological cancer treated by radical surgery, high prevalence of anxiety and depression symptoms was found. Social support and high self-esteem could help improve mental health issues related to this type of cancer.

Identifiants

pubmed: 33752868
pii: S0007-4551(21)00071-0
doi: 10.1016/j.bulcan.2020.12.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

472-480

Informations de copyright

Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Amina Aquil (A)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and biomedical unit, 26000 Settat, Morocco.

Ouassil El Kherchi (OE)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and biomedical unit, 26000 Settat, Morocco.

Naoual E L Azmaoui (NEL)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and biomedical unit, 26000 Settat, Morocco.

Mustapha Mouallif (M)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and biomedical unit, 26000 Settat, Morocco.

Maroua Guerroumi (M)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and biomedical unit, 26000 Settat, Morocco.

Hasna Zaeria (H)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and biomedical unit, 26000 Settat, Morocco.

Arumugam R Jayakumar (AR)

Gynecology and Reproductive Sciences University of Miami Miller School of Medicine, Miami VA Medical Center and Department of Obstetrics, Neuropathology Research Unit, 33136 Miami, FL, USA.

Abdellatif Benider (A)

Ibn-Rochd University Hospital Center, Mohammed VI Center for the Treatment of Cancers, Casablanca, Morocco.

Abdeljalil Elgot (A)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and biomedical unit, 26000 Settat, Morocco. Electronic address: abdeljalil.elgot@uhp.ac.ma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH